scPharmaceuticals SG&A Expense (TTM) Analysis

scPharmaceuticals Inc (SCPH)

4.21 -0.11 (-2.55%) USD | NASDAQ | Jul 02, 16:00

4.23 +0.02 (+0.48%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	59.92M
December 31, 2023	53.37M
September 30, 2023	44.30M
June 30, 2023	36.44M
March 31, 2023	28.63M
December 31, 2022	20.62M
September 30, 2022	15.64M
June 30, 2022	11.57M
March 31, 2022	9.944M
December 31, 2021	9.783M
September 30, 2021	11.02M
June 30, 2021	12.12M
March 31, 2021	12.01M
December 31, 2020	11.78M

Date	Value
September 30, 2020	10.47M
June 30, 2020	9.151M
March 31, 2020	8.453M
December 31, 2019	8.273M
September 30, 2019	8.232M
June 30, 2019	8.181M
March 31, 2019	11.39M
December 31, 2018	13.72M
September 30, 2018	14.64M
June 30, 2018	14.36M
March 31, 2018	11.68M
December 31, 2017	9.105M
September 30, 2017	7.056M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

8.232M

Minimum

Sep 2019

59.92M

Maximum

Mar 2024

20.09M

Average

11.78M

Median

Dec 2020

SG&A Expense (TTM) Benchmarks